INTRODUCTION
T he activation of both humoral (46) and cellular (71) immunity has been detected in Hansen's Disease (17,18). Especially in the lepromatous form, the polyclonal activation of B-cells has been known since the 1960's by means of anti body detection and seric hypergammaglobulinemia and is considered to be due to the chronicity of the disease. On the other hand, specific antibodies against the mycobacteria (03,31,44), other mycobacterial immunoglobulins (15) and autoantibodies have been described (20,21 ,23,27,38,51,61,67) , as in other infectious diseases (01, 10, 11, 26, 30, 37, 42, 43, 50, 60) , and are important for analysis and diagnosis (57, 58, 65) .
SPECIFIC ANTIBODIES
In 1982, Hunter et al. (44) , chemically described a glycolipid from Mycobacterium leprae cultivated in armadillos. Later the same structure was found in infected human tissues. Through enzyme-linked immunosorbent assay (ELISA), it was shown that these antibodies were specific to theM. leprae infection (19, 40) and that patients with tuberculosis and other mycobacterial infections did not show any reaction to this antigen. The false-positive rate was 3%, and lepromatous patients presented the most significant rates of these antibodies called anti-phenolic glycolipid-I antibodies (anti-PGL-I) (84) . Due to the low presence of levels of anti-PGL-I in patients exposed to the ELISA test for this antibody, is not cosidered diagnostic (34) but has been considered useful for epidemiological studies, especially in endemic areas (19, 75) and patients that have been in contact with leprosy.
Recent studies have shown that the scope and magnitude of antibodies produced by mice against certain mycobacterial proteins may vary greatly (16). In studies with M.leprae, it is believed that these different responses are influenced by. genetic background. After inoculating mice with M.leprae sonicate and the recombinant 65kDa protein, differences in the number and structure of the recognized epitopes were noted, and the participation of non-H2 genes was demonstrated (04).
AUTOANTIBODIES
Among rabbits, bacterial immunization causes development of antigammaglobulins very similar to the rheumatoid factor (01). Late, anti-DNA antibodies may be found along with proliferative glomerulonephritis diagnosed during autopsy (25). However, in Hansen's Disease, the sole presence of these antibodies has not been related to any specific clinical manifestation, except when immune complex deposits occur. In 1966, Azevedo and Melo (06) recognized that the decrease in complement activation in reactional states of leprosy is due to the complement binding by the antigen-antibody complexes.
The autoantibodies in Hansen's Disease appear at different rates that vary according to the population studied, to the methods used and to the period in which they were carried out. Although some study groups have shown a higher prevalence of Hansen's Disease than in the control groups (62) antibodies and/or a crossreaction with the mycobacterial antigenic components.
The production of antibodies is more characteristic of the lepromatous form (23, 52, 64) , demonstrated by high titers of gammaglobulin (02,03,73) especially in the reactional states, and can be detected also in patients in disease remission (82) . An inverse relation between the antibody and the celular reactions has also been suggested (63). Long duration of disease, old age, and a history of reccurring erithema nodosum leprosum (ENL) predispose the formation of autoantibodies in these patients (63).
In several studies (05,14,20,21,23, 47, 52, 64, 66, 68) . the detection of the rheumatoid factor ranges from zero (55) to 100% (28). Since the latex fixation test is more sensitive and less specific than the Waaler-Rose test, it can be assumed that this sensitivity could contribute to these differences in rate. In addition, in studies where the rates are very high, the number of patients studied is low (08). The identification of senc rheumatoid factor in leprosy patients occurs both in tuberculoid and lepromatous forms, although with a higher incidence in the latter (64) . According to Pechclai et al.. (64) , rheumatoid factor titers can be low, depending on the population chosen. In hospitalized patients titers up to 1:5120 were found (21).
The production of seric factors very similar to rheumatoid factor can be stimulated by microorganisms (rabbit hyperimmunization with Escherichia coli and Bacillus subtilis) (0 I). No correlation was found with arthritis or rheumatoid disease in these subjects.
It is known that rheumatoid factors were also detected in infections such as tuberculosis (83) and syphilis (60) .
Antinuclear factors and L.E. cells were studied in leprosy patients as an attempt to diagnose a possible association with connective tissue diseases (74), since joint and skin manifestations may mimic several rheumatic symptons. Similary to rheumatoid factor, the rates found (08,23,47) varied greatly, ranging from zero (55) to 29% (14, 63) . Although L.E. cells have been found (14, 47, 52) and leprosy patients with lupoid aspects have been reported (12) the association with systemic lupus erythematosus was not significant. Autoantibodies reactive to native or denatured collagen type II were detected in the serum of 11 out of 20 patients with the lepromatous form in which antibody levels were significantly higher than those with rheumatoid disease; however, none of these patients had any signs of arthritis (24).
CIRCULATING IMMUNE COMPLEXES (22, 69, 70, 85) , CRYOGLOBULINS (52) AND COMPLEMENT (22) Although the presence of autoantibodies does not always mean pathogenicity, the presence of immune complexes in the tissues does suggest some participation in clinical manifestations (86) The perivascular immune complexes seen in the dermis, and bound to soluble mycobacterial antigens were detected in patients with ENL, suggesting a possible role in its pathogenesis (56) . Immune complexes have also been demonstrated in renal biopsies of leprosy patients (32) and related to a decrease in complement in these patients (09).
Patients with borderline leprosy in reaction showed circulating immune complexes (IgG and the C3 fraction), while in lepromatous leprosy immune complexes were formed by rheumatoid factor and IgM, especially in those patients with arthritis (59), anti-mycobacterial antibodies and cryoglobulins (13) . By using the C1q reaction method, immune complexes were also identified in the serum of the patients with the tuberculoid form, in contrast to previous studies that showed elevated immunecomplexes only during ENL Reaction (72 
